Algert Global’s Pliant Therapeutics PLRX Stock Holding History

Algert Global’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	123,402 +38,950	+46%	+$47.4K	﹤0.01%	1207
2026 Q1	$106K	Hold	84,452	–	–	﹤0.01%	1107
2025 Q4	$103K	Sell	84,452 -19,930	-19%	-$29.9K	﹤0.01%	1093
2025 Q3	$154K	Buy	104,382 +15,692	+18%	+$23.9K	﹤0.01%	1062
2025 Q2	$103K	Hold	88,690	–	–	﹤0.01%	1138
2025 Q1	$120K	Sell	88,690 -18,913	-18%	-$115K	﹤0.01%	1122
2024 Q4	$1.42M	Buy	107,603 +1,041	+1%	+$14.2K	0.03%	709
2024 Q3	$1.19M	Buy	106,562 +36,720	+53%	+$459K	0.03%	713
2024 Q2	$751K	Buy	69,842 +52,912	+313%	+$682K	0.03%	761
2024 Q1	$252K	Hold	16,930	–	–	0.01%	925
2023 Q4	$307K	Buy	+16,930	New	+$257K	0.01%	935
2023 Q3	–	Sell	-28,000	Closed	-$507K	–	1218
2023 Q2	$507K	Sell	28,000 -2,650	-9%	-$62.7K	0.02%	810
2023 Q1	$815K	Buy	+30,650	New	+$873K	0.04%	705
2022 Q3	–	Sell	-36,020	Closed	-$289K	–	1304
2022 Q2	$289K	Buy	+36,020	New	+$231K	0.02%	926

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Algert Global's PLRX Position: Q2 2026 in Review

Algert Global increased its Pliant Therapeutics (PLRX) stake by 46% in Q2 2026, buying an estimated $47.4K and bringing the position to 123,402 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Algert Global first reported a position in PLRX in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.42M in Q4 2024. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Algert Global held 123,402 shares of Pliant Therapeutics worth $141K as of Q2 2026.
Algert Global bought 38,950 Pliant Therapeutics shares in Q2 2026, an estimated $47.4K.
Pliant Therapeutics made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1207 holding.
Algert Global first reported a position in Pliant Therapeutics in Q2 2022 and has held it in 14 quarters since.
Algert Global's Pliant Therapeutics position peaked at $1.42M in Q4 2024.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.